Stillwater
Respiron is developing an antiviral drug, RN-1, to treat any existing and emerging strains of influenza virus. It can potentially cure flu symptoms in nearly 300 million people worldwide regardless of virus mutation.
Oklahoma City
Hyalose specializes in Hyaluronic Acid production and application. The Emergent Technologies Inc....
Edmond
Leviathan proposes a next-generation tool that will make it possible to distinguish and examine h...
Oklahoma City
Tetherex is developing a treatment for inflammatory and thrombotic diseases such as Crohn’s...
Oklahoma City
Charlesson is an ocular pharmaceutical company that is developing therapeutics for various eye di...
Oklahoma City
Ecolab Inc. (Ecolab) develops and markets products and services for the hospitality, foodservice,...
Edmond
UltraBotanica has developed a patented method to bind curcumin to whey protein, effectively incre...
Oklahoma City
Anastasia Marie Labs, Inc. specializes in over-the-counter diabetic skin treatment products.
Oklahoma City
Analytical testing laboratory that provides innovative methodologies for greater flexibility and ...
Oklahoma CIty
Sensuli, LLC is developing a true once-a-day glucose-responsive insulin that may mimic a healthy ...
Oklahoma City
Cytovance? Biologics adds significant value to biopharmaceutical development programs assisting c...
Oklahoma City
Choncept?s scientific innovation is focused on development of new technology to produce chondroit...
Oklahoma City
Arthrokinex is a comprehensive joint health program that can reduce or eliminate joint pain from ...
Oklahoma City
IPS Research Company provides phase 1-4 inpatient and outpatient clinical trials. IPS Research sp...
Oklahoma City
Jortan Pharmaceuticals Inc.?(JORTAN) was founded around aspartic protease inhibitors as potential...
Oklahoma City
Heparinex is a biotechnology company focused on the development of novel recombinant synthesis of...
Plymouth Pharmaceuticals, Inc. is a leading research and development company exploring safe, effe...
Oklahoma City
The Lupus Multiplex Registry and Repository is finding the genes that cause lupus (also known as ...
Oklahoma City
EpimedX, LLC is a biotechnology company that was founded in 2011 with the mission to develop Gene...
Oklahoma City
DormaTarg, Inc is a biotechnology company researching and developing therapeutic drugs for cancer...
Oklahoma City
PreDENT has developed a vaccine to help prevent gingivitis and periodontal disease in pets?that p...